JF
Jessica Fye JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
69
Avg Return
Past Year
Past Year
6.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
70%
Neutral
30%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $473 |
4%
downside
| 2 | +12% |
0
%
| 13 Oct ‘25 7 days ago |
|
|
|
Overweight
Maintained
| $76 |
132%
upside
| 2 | -3.9% |
0
%
| 9 Oct ‘25 11 days ago |
|
|
|
Neutral
Maintained
| $89 |
2%
upside
| 2 | – |
–
| 9 Oct ‘25 11 days ago |
|
|
|
Overweight
Maintained
| $119 |
124%
upside
| 1 | -8.5% |
0
%
| 9 Oct ‘25 11 days ago |
|
|
|
Overweight
Maintained
| $264 |
27%
upside
| 3 | +5.9% |
0
%
| 9 Oct ‘25 11 days ago |
|
|
|
Overweight
Maintained
| $530 |
26%
upside
| 1 | -1.3% |
0
%
| 8 Oct ‘25 12 days ago |
|
|
|
Overweight
Maintained
| $385 |
21%
upside
| 1 | +8.1% |
0
%
| 8 Oct ‘25 12 days ago |
|
|
|
Overweight
Upgraded
| $80 |
9%
upside
| 2 | +6.6% |
0
%
| 8 Oct ‘25 12 days ago |
|
|
|
Overweight
Maintained
| $52 |
23%
upside
| 1 | +18% |
0
%
| 24 Sep ‘25 26 days ago |
|
|
|
Neutral
Maintained
| $121 |
12%
upside
| 1 | – |
–
| 22 Sep ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $77 |
5%
upside
| 1 | -3.6% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $35 |
12%
upside
| 1 | – |
–
| 9 Sep ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $135 |
19%
downside
| 1 | +23% |
0
%
| 20 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $63 |
6%
downside
| 1 | – |
–
| 7 Aug ‘25 2 months ago |
|